ArticlePreventive medicine reports2026
Prevalence of hypertension in Europe: a pooled analysis of 68,047 adults from 27 countries.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study analysed the prevalence of self-reported current/previous hypertension diagnosis in Europe. Methods: We used data from the Survey of Health, Ageing and Retirement in Europe (2021-2022), covering 68,047 adults aged 50+ years across 27 countries. Weighted prevalence estimates were calculated and stratified by gender, age group (50-64, 65-79, ≥80 years), and European regions. Results: Among individuals aged 50-64 years, men had a higher prevalence of hypertension diagnosis (39.4% vs. 33.5%). In the 65-79 age group, prevalence was comparable between genders (women: 63.1%, men: 62.6%). In the 80+ age group, women had higher prevalence (78.0% vs. 71.8%). Still, this pattern varied across European regions. Central/Eastern and Southern Europe consistently showed higher prevalence of hypertension compared with Northern and Western regions. Conclusions: The prevalence of hypertension in Europe increases with ageing and differs by gender and region. The burden is greatest in Central/Eastern and Southern Europe, highlighting the need for region-specific strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.